BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26828647)

  • 1. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.
    Verma V; Mishra MV; Mehta MP
    Cancer; 2016 May; 122(10):1483-501. PubMed ID: 26828647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
    Verma V; Simone CB; Mishra MV
    J Natl Cancer Inst; 2018 Apr; 110(4):. PubMed ID: 29028221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
    Verma V; Mehta MP
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes and Toxicity of Proton Radiotherapy for Breast Cancer.
    Verma V; Shah C; Mehta MP
    Clin Breast Cancer; 2016 Jun; 16(3):145-54. PubMed ID: 26995159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-comparativeness of proton versus photon therapy.
    Verma V; Shah C; Rwigema JC; Solberg T; Zhu X; Simone CB
    Chin Clin Oncol; 2016 Aug; 5(4):56. PubMed ID: 27506804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013.
    Amin NP; Sher DJ; Konski AA
    Appl Health Econ Health Policy; 2014 Aug; 12(4):391-408. PubMed ID: 25022451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials.
    Mishra MV; Aggarwal S; Bentzen SM; Knight N; Mehta MP; Regine WF
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):228-235. PubMed ID: 28068231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton radiotherapy for gynecologic neoplasms.
    Verma V; Simone CB; Wahl AO; Beriwal S; Mehta MP
    Acta Oncol; 2016 Nov; 55(11):1257-1265. PubMed ID: 27500710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.
    Sher DJ; Tishler RB; Pham NL; Punglia RS
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):875-882. PubMed ID: 29976499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finding Value for Protons: The Case of Prostate Cancer?
    Ojerholm E; Bekelman JE
    Semin Radiat Oncol; 2018 Apr; 28(2):131-137. PubMed ID: 29735189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review.
    Verma V; Lin SH; Simone CB; Mehta MP
    J Gastrointest Oncol; 2016 Aug; 7(4):644-64. PubMed ID: 27563457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
    Verma V; Rwigema JM; Malyapa RS; Regine WF; Simone CB
    Radiother Oncol; 2017 Oct; 125(1):21-30. PubMed ID: 28941560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative radiotherapy of sarcoma: Proton beam radiation.
    DeLaney TF; Haas RL
    Eur J Cancer; 2016 Jul; 62():112-23. PubMed ID: 27258968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Review of the Economic Burden of Proton Therapy in Head and Neck Cancer.
    Bharathi R P; Ms A; Kamath A
    Asian Pac J Cancer Prev; 2023 Nov; 24(11):3643-3653. PubMed ID: 38019221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton beam therapy and accountable care: the challenges ahead.
    Elnahal SM; Kerstiens J; Helsper RS; Zietman AL; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):e165-72. PubMed ID: 23265572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer.
    Barbieri M; Weatherly HL; Ara R; Basarir H; Sculpher M; Adams R; Ahmed H; Coles C; Guerrero-Urbano T; Nutting C; Powell M
    Appl Health Econ Health Policy; 2014 Oct; 12(5):497-510. PubMed ID: 25060829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial.
    Galland-Girodet S; Pashtan I; MacDonald SM; Ancukiewicz M; Hirsch AE; Kachnic LA; Specht M; Gadd M; Smith BL; Powell SN; Recht A; Taghian AG
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):493-500. PubMed ID: 24880212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hadrontherapy for cancer. An overview of HTA reports and ongoing studies.
    Jefferson T; Formoso G; Venturelli F; Vicentini M; Chiarolla E; Ballini L
    Recenti Prog Med; 2019 Dec; 110(12):566-586. PubMed ID: 31909760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
    Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
    Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.